Physician profile
Michael J Greller
NPI 1194799346
$8,672.88
in general payments reported to CMS, 2019-2025
20 companies · $840 in 2025
The $840 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $981 · 2021: $104 · 2022: $2,668 · 2023: $1,761 · 2024: $1,875 · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,607 · Travel and Lodging: $1,868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,607.35 |
| Travel and Lodging | $1,868.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $2,815.77 | 2020-2025 | |
| Arthrex, INC. | $1,909.43 | 2022-2024 | |
| Stryker Corporation | $1,126.04 | 2019-2024 | Mako, Motionsense Digital Goniometer |
| Miach Orthopaedics, INC. | $790.42 | 2023-2024 | |
| Smith+Nephew, INC. | $461.83 | 2022-2025 | Intellio Link Werewolf, N/A, Bone Anchors With Arthroscopic Delivery System |
| Bioventus LLC | $337.12 | 2020-2024 | Durolane |
| Depuy Synthes Sales INC. | $240.66 | 2019-2025 | Orthovisc, Monovisc, Dynacord |
| Vericel Corporation | $174.77 | 2019-2025 | Maci |
| Zimmer Biomet Holdings, INC. | $155.10 | 2019-2025 | Gel-One Cross-Linked Hyaluronate |
| Abbott Laboratories | $126.40 | 2023-2024 | Eterna, Proclaim |
| Intuitive Surgical, INC. | $100.33 | 2023 | |
| Ethicon US, LLC | $90.87 | 2019-2023 | Stratafix |
| Mml US, INC. | $70.47 | 2025 | Reactiv8 |
| Nalu Medical, INC. | $65.23 | 2023-2025 | Nalu Neurostimulation System |
| Averitas Pharma INC. | $53.11 | 2024-2025 | Qutenza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $49.50 | 2022-2023 | Trivisc Sodium Hyaluronate |
| Collegium Pharmaceutical, INC. | $35.18 | 2025 | Belbuca |
| Biotronik Nro, INC. | $32.90 | 2023 | Biotronik |
| Medtronic, INC. | $21.44 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Greller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.